cycloheximide has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcas-García, A; Comabella, M; Comas-Casellas, E; Ejarque-Ortíz, A; Magallon-Lorenz, M; Malhotra, S; Martín, M; Martínez-Barriocanal, Á; Montalban, X; Negro-Demontel, ML; Peluffo, H; Sayós, J; Schwartz, S | 1 |
| Dawson, DM; Hafler, DA; Hohol, MJ; Khoury, SJ; Olek, MJ; Orav, EJ; Stazzone, L; Weiner, HL | 1 |
2 other study(ies) available for cycloheximide and Multiple Sclerosis
| Article | Year |
|---|---|
Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis.
Topics: Adult; Amino Acid Sequence; Animals; Binding Sites; Case-Control Studies; Chlorocebus aethiops; COS Cells; Cycloheximide; Female; Gene Expression; Humans; Ligands; Male; Monocytes; Multiple Sclerosis; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Protein Structure, Tertiary; Receptors, Immunologic | 2017 |
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Topics: Adult; Age of Onset; Cycloheximide; Databases, Factual; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure | 1999 |